| Dennis Kolokolo, MD | |
|
1616 W Cumberland Rd, Bluefield, VA 24605-2005 | |
| (276) 326-1618 | |
| (276) 326-1618 |
| Full Name | Dennis Kolokolo |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 42 Years |
| Location | 1616 W Cumberland Rd, Bluefield, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477575355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 27434 (Oklahoma) | Secondary |
| 207R00000X | Internal Medicine | MD2022-0355 (New Mexico) | Primary |
| 207R00000X | Internal Medicine | 0101229030 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Merit Health River Region | Vicksburg, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vicksburg Healthcare Llc | 4688575129 | 8 |
News Archive
According to a new report by the World Health Organization (WHO), UNAIDS and UNICEF, only 28% of the world's poor with HIV have access to the antiretroviral drugs that could save their lives.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II clinical study of Archexin, its clinical-stage oncology drug candidate.
A large meta-analysis conducted by researchers at Moffitt Cancer Center has concluded that breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits after treatment.
Scientists have uncovered critical new details about the mechanisms that modulate the response of ovarian cancer cells to chemotherapy.
Study findings suggest that women who use at least two types of cleaning spray on a weekly basis to clean their homes may be putting themselves at an increased risk for asthma.
› Verified 2 days ago
| Entity Name | Vicksburg Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629084058 PECOS PAC ID: 4688575129 Enrollment ID: O20040213000299 |
News Archive
According to a new report by the World Health Organization (WHO), UNAIDS and UNICEF, only 28% of the world's poor with HIV have access to the antiretroviral drugs that could save their lives.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II clinical study of Archexin, its clinical-stage oncology drug candidate.
A large meta-analysis conducted by researchers at Moffitt Cancer Center has concluded that breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits after treatment.
Scientists have uncovered critical new details about the mechanisms that modulate the response of ovarian cancer cells to chemotherapy.
Study findings suggest that women who use at least two types of cleaning spray on a weekly basis to clean their homes may be putting themselves at an increased risk for asthma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Kolokolo, MD 1145 S Utica Ave, Ste 460, Tulsa, OK 74104-4041 Ph: (918) 579-5749 | Dennis Kolokolo, MD 1616 W Cumberland Rd, Bluefield, VA 24605-2005 Ph: (276) 326-1618 |
News Archive
According to a new report by the World Health Organization (WHO), UNAIDS and UNICEF, only 28% of the world's poor with HIV have access to the antiretroviral drugs that could save their lives.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II clinical study of Archexin, its clinical-stage oncology drug candidate.
A large meta-analysis conducted by researchers at Moffitt Cancer Center has concluded that breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits after treatment.
Scientists have uncovered critical new details about the mechanisms that modulate the response of ovarian cancer cells to chemotherapy.
Study findings suggest that women who use at least two types of cleaning spray on a weekly basis to clean their homes may be putting themselves at an increased risk for asthma.
› Verified 2 days ago
Dr. Naeem A Qazi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Westwood Medical Park, Bluefield, VA 24605 Phone: 276-326-1136 Fax: 276-326-1137 | |
Mohammad Javed Rana, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2003 Leatherwood Ln, Bluefield, VA 24605 Phone: 276-322-0000 Fax: 276-322-0003 | |
Dr. Oscar Fernando Figueroa, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 103 Westwood Cmn, Bluefield, VA 24605 Phone: 276-322-3947 Fax: 276-322-2344 | |
Dr. Jack Charles Meshel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Westwood Medical Park, Bluefield, VA 24605 Phone: 276-326-1995 Fax: 276-326-1996 | |
Ashutosh Chandel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Westwood Commons, Bluefield, VA 24605 Phone: 276-326-1915 Fax: 276-326-1917 | |
Dr. Jonathan R Hall, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 725 S College Ave, Bluefield, VA 24605 Phone: 276-326-3376 | |
Kimberly Ann Matzel, PAC Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2111 College Ave, Bluefield Internal Medicine, Bluefield, VA 24605 Phone: 276-322-4661 Fax: 276-322-4663 |